Deepak Singhal

Port Road
Adelaide, SA, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Long-Term Survival Gains after Allogeneic Hematopoietic Stem Cell Transplant are Driven by Reductions in Non-Relapse Mortality: A 35-Year Statewide Australian Cohort Study.

Long-Term Survival Gains after Allogeneic Hematopoietic Stem Cell Transplant are Driven by Reductions in Non-Relapse Mortality: A 35-Year Statewide Australian Cohort Study.

Journal: Transplantation and cellular therapy

Published: November 13, 2025

Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years.

Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years.

Journal: Nature communications

Published: May 31, 2024

NCI's Proteomic Data Commons: A Cloud-Based Proteomics Repository Empowering Comprehensive Cancer Analysis through Cross-Referencing with Genomic and Imaging Data.

NCI's Proteomic Data Commons: A Cloud-Based Proteomics Repository Empowering Comprehensive Cancer Analysis through Cross-Referencing with Genomic and Imaging Data.

Journal: Cancer research communications

Published: April 26, 2024

Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment.

Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment.

Journal: Blood cancer discovery

Published: April 26, 2024

A Personalized Risk Model for Azacitidine Outcome in Myelodysplastic Syndrome and Other Myeloid Neoplasms Identified by Machine Learning Model Utilizing Real-World Data.

A Personalized Risk Model for Azacitidine Outcome in Myelodysplastic Syndrome and Other Myeloid Neoplasms Identified by Machine Learning Model Utilizing Real-World Data.

Journal: Cancers

Published: May 27, 2023

Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41.

Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41.

Journal: Blood advances

Published: February 23, 2023

TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.

TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.

Journal: Blood cancer journal

Published: January 19, 2023

Factors predicting survival following alloSCT in patients with therapy-related AML and MDS: a multicenter study.

Factors predicting survival following alloSCT in patients with therapy-related AML and MDS: a multicenter study.

Journal: Bone marrow transplantation

Published: December 01, 2022

Personalized risk model for predicting risk of acute coronary syndrome in patients with myelodysplastic syndromes.

Personalized risk model for predicting risk of acute coronary syndrome in patients with myelodysplastic syndromes.

Journal: Blood advances

Published: October 21, 2022

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.

Journal: Blood

Published: September 06, 2022

Optimizing antifungal prophylaxis in allogeneic stem cell transplantation: A cohort study of two different approaches.

Optimizing antifungal prophylaxis in allogeneic stem cell transplantation: A cohort study of two different approaches.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: July 10, 2022

Proteogenomic data and resources for pan-cancer analysis.

Proteogenomic data and resources for pan-cancer analysis.

Journal: Cancer cell

Published: July 08, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026